326 related articles for article (PubMed ID: 29921315)
1. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
Donzelli S; Milano E; Pruszko M; Sacconi A; Masciarelli S; Iosue I; Melucci E; Gallo E; Terrenato I; Mottolese M; Zylicz M; Zylicz A; Fazi F; Blandino G; Fontemaggi G
Breast Cancer Res; 2018 Jun; 20(1):59. PubMed ID: 29921315
[TBL] [Abstract][Full Text] [Related]
2. Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages.
Donzelli S; Sacconi A; Turco C; Gallo E; Milano E; Iosue I; Blandino G; Fazi F; Fontemaggi G
Cells; 2020 Feb; 9(2):. PubMed ID: 32054109
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
[TBL] [Abstract][Full Text] [Related]
4. The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.
Fontemaggi G; Dell'Orso S; Trisciuoglio D; Shay T; Melucci E; Fazi F; Terrenato I; Mottolese M; Muti P; Domany E; Del Bufalo D; Strano S; Blandino G
Nat Struct Mol Biol; 2009 Oct; 16(10):1086-93. PubMed ID: 19783986
[TBL] [Abstract][Full Text] [Related]
5. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
Thike AA; Tan PH; Ikeda M; Iqbal J
Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
[TBL] [Abstract][Full Text] [Related]
6. CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors.
Nasif D; Real S; Roqué M; Branham MT
Breast Cancer; 2022 May; 29(3):562-573. PubMed ID: 35094293
[TBL] [Abstract][Full Text] [Related]
7. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.
Crippa E; Lusa L; De Cecco L; Marchesi E; Calin GA; Radice P; Manoukian S; Peissel B; Daidone MG; Gariboldi M; Pierotti MA
PLoS One; 2014; 9(1):e87039. PubMed ID: 24475217
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
Noetzel E; Veeck J; Niederacher D; Galm O; Horn F; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2008 May; 8():154. PubMed ID: 18513385
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
[TBL] [Abstract][Full Text] [Related]
11. miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α.
Wu Z; Cai X; Huang C; Xu J; Liu A
Oncol Rep; 2016 Mar; 35(3):1696-702. PubMed ID: 26718330
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
13. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
14. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression.
Wang P; Xu LJ; Qin JJ; Zhang L; Zhuang GH
Biochem Biophys Res Commun; 2018 Sep; 503(2):452-458. PubMed ID: 29660336
[TBL] [Abstract][Full Text] [Related]
16. microRNA-1228
Jia L; Chen J; Xie C; Shao L; Xu Z; Zhang L
Life Sci; 2017 Jul; 180():9-16. PubMed ID: 28465246
[TBL] [Abstract][Full Text] [Related]
17. miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.
D'Ippolito E; Plantamura I; Bongiovanni L; Casalini P; Baroni S; Piovan C; Orlandi R; Gualeni AV; Gloghini A; Rossini A; Cresta S; Tessari A; De Braud F; Di Leva G; Tripodo C; Iorio MV
Cancer Res; 2016 Sep; 76(18):5562-72. PubMed ID: 27402080
[TBL] [Abstract][Full Text] [Related]
18. Protein-Bound Polysaccharides from
Jędrzejewski T; Pawlikowska M; Sobocińska J; Wrotek S
Cell Physiol Biochem; 2020 Jun; 54(4):615-628. PubMed ID: 32559360
[TBL] [Abstract][Full Text] [Related]
19. The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.
Pruszko M; Milano E; Forcato M; Donzelli S; Ganci F; Di Agostino S; De Panfilis S; Fazi F; Bates DO; Bicciato S; Zylicz M; Zylicz A; Blandino G; Fontemaggi G
EMBO Rep; 2017 Aug; 18(8):1331-1351. PubMed ID: 28652379
[TBL] [Abstract][Full Text] [Related]
20. Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer.
Roldán G; Delgado L; Musé IM
Cancer Biol Ther; 2006 May; 5(5):505-10. PubMed ID: 16582598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
